Vivos Therapeutics annual total assets
2019
2020
2021
2022
2023
2024
2025
Vivos Therapeutics Total Assets Growth & History (VVOS)
Vivos Therapeutics's total assets was $25.2M for fiscal 2025.
View full Vivos Therapeutics company overviewVivos Therapeutics annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $25.2M | $9.9M | +64.56% |
| 2024 | 2024-12-31 | $15.3M | $4.6M | +42.44% |
| 2023 | 2023-12-31 | $10.7M | −$3.0M | −21.79% |
| 2022 | 2022-12-31 | $13.7M | −$20.0M | −59.27% |
| 2021 | 2021-12-31 | $33.7M | $8.4M | +33.02% |
| 2020 | 2020-12-31 | $25.3M | $17.8M | +235.39% |
| 2019 | 2019-12-31 | $7.6M | — | — |
Vivos Therapeutics quarterly total assets
Q4.19
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $24.1M | −$1.9M | −7.26% |
| Q1 2026 | 2026-03-31 | $25.0M | $13.8M | +121.97% |
| Q4 2025 | 2025-12-31 | $25.2M | $9.9M | +64.56% |
| Q3 2025 | 2025-09-30 | $25.6M | $10.3M | +67.09% |
| Q2 2025 | 2025-06-30 | $26.0M | $10.2M | +64.33% |
| Q1 2025 | 2025-03-31 | $11.3M | −$522,000 | −4.42% |
| Q4 2024 | 2024-12-31 | $15.3M | $4.6M | +42.44% |
| Q3 2024 | 2024-09-30 | $15.3M | $5.0M | +48.75% |
| Q2 2024 | 2024-06-30 | $15.8M | $2.1M | +15.22% |
| Q1 2024 | 2024-03-31 | $11.8M | −$5.3M | −30.97% |
| Q4 2023 | 2023-12-31 | $10.7M | −$3.0M | −21.79% |
| Q3 2023 | 2023-09-30 | $10.3M | −$8.1M | −43.93% |
| Q2 2023 | 2023-06-30 | $13.7M | −$10.6M | −43.59% |
| Q1 2023 | 2023-03-31 | $17.1M | −$12.5M | −42.14% |
| Q4 2022 | 2022-12-31 | $13.7M | −$20.0M | −59.27% |
| Q3 2022 | 2022-09-30 | $18.4M | −$22.6M | −55.15% |
| Q2 2022 | 2022-06-30 | $24.4M | −$21.8M | −47.19% |
| Q1 2022 | 2022-03-31 | $29.6M | $7.6M | +34.63% |
| Q4 2021 | 2021-12-31 | $33.7M | $8.4M | +33.02% |
| Q3 2021 | 2021-09-30 | $41.0M | — | — |
| Q2 2021 | 2021-06-30 | $46.2M | — | — |
| Q1 2021 | 2021-03-31 | $22.0M | — | — |
| Q4 2020 | 2020-12-31 | $25.3M | $17.8M | +235.39% |
| Q4 2019 | 2019-12-31 | $7.6M | — | — |
Vivos Therapeutics total assets trends
Over the last five fiscal years, Vivos Therapeutics's total assets decreased from $25.3M to $25.2M, a change of −$175,000. The latest reported quarter, Q2 2026, shows $24.1M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Vivos Therapeutics source filings ↗